Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye Prophylaxis in the Newborn
NCT00000120Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Jan 1985
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of erythromycin and silver nitrate in ophthalmia neonatorum (ON) (3 arms), sponsored by National Eye Institute. Primary endpoint: Incidence of neonatal conjunctivitis at 2 months. Started Jan 1985; status: completed.
02
Drugs
erythromycinsilver nitrate
03
Conditions
ophthalmia neonatorum (ON)
Beyond the preview
Go deeper on NCT00000120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000120.